AU Stock MarketDetailed Quotes

RCE Recce Pharmaceuticals Ltd

Watchlist
  • 0.445
  • -0.005-1.11%
20min DelayNot Open Dec 20 16:00 AET
103.18MMarket Cap-4.45P/E (Static)

About Recce Pharmaceuticals Ltd Company

Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. The company operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat diseases caused by various bacteria namely Sepsis, Neisseria gonorrhoeaei, Escherichia coli, Mycobacterium abscessus, and others.

Company Profile

SymbolRCE
Company NameRecce Pharmaceuticals Ltd
Founded2007
MarketASX
Fiscal Year Ends06-30
Address180 George Street Level 23
CitySydney
CountryAustralia
Zip Code2000
Phone+61 292562505
Share RegistryAUTOMIC REGISTRY SERVICES Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000 02 9698 5414

Company Executives

  • Name
  • Position
  • Salary
  • James Graham
  • Director,Managing Director and Chief Executive Officer
  • --
  • Michele Dilizia
  • Executive Director and Chief Scientific Officer
  • --
  • Justin Reynolds
  • Chief Financial Officer
  • --
  • John Prendergast
  • Executive Chairman of the Board
  • --
  • Dr Alan Dunton
  • Non-Executive Director and Chief Medical Advisor
  • --
  • Dr Justin Ward
  • Executive Director and Principal Quality Chemist
  • --
  • Alistair Gregory McKeough
  • Non-Executive Director
  • --
  • Maggie Niewidok
  • Company Secretary
  • --
  • Arthur Kollaras
  • Principal Engineer & Head of Manufacturing
  • --